Close this search box.

Oxford Global R&D Series: VIRTUAL

About the event: Oxford Global R&D Series


POSTPONED to 29-30 July 2020 as a virtual event


The R&D Series features 3 outstanding programmes bringing together Europe’s most successful pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in ​therapeutic areas. The event includes over 100 cutting-edge presentations and workshops, over 8 hours of valuable networking sessions, and an exhibition hall showcasing 40 vendor companies.


Taros’ participants


Taros’ Drug Discovery Experts are invited to share their outstanding industry expertise with other professional from industry and academia

Dr. Dimitrios Tzalis, CEO as speaker on “the European Lead Factory (ELF) – the success story continues” within a virtual round table session on Drug Discovery Partnership Models Interactive Panel discussion and Open Address

Dr. Torsten Hoffmann, SVP Drug Discovery as invited Keynote Lecturer: “From Small Molecules, To Peptide Therapeutics And Oligoribonucleotides – 3 Short Stories In Drug Discovery”


Are you going to attend the event? contact us in advance to arrange a personal meeting

Taros computational chemistry expertise encompasses the whole spectrum of computer-aided drug design, from virtual screening to adaptive SAR analysis as well as molecular modelling to statistical forecasting.

Drug Discovery Chemistry

Medicinal Chemistry

In Medicinal Chemistry research, we are working with a broadly experienced team on all biomolecular targets from any gene family in any therapeutic area…

Discovery and Optimization of synthetic routes in organic chemistry research

Discovery Chemistry

Custom Synthesis

As a leading Contract Research Organization in Europe, Taros provides valuable contract discovery for synthetic organic chemistry, chemical process development, and…

Looks interesting?

As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
Scroll to Top